Alejandro Roman, MBA

Executive Director

Alex is a health entrepreneur and boundary spanner, with a formal background in health economics and business of health, specializing in chronic disease management, remote care, telemedicine, digital health, and population health (ACA, HealthCentrix, ADNGenomix). He pioneered interoperable digital health technologies for the acquisition, integration, and operationalization of clinical data to create intelligent care plans, novel patient experience, and sustainable business models.

Kjell deOrr, MBA

Director, Strategic Partnerships

​Kjell has more than 25 years of international experience leading Insights, Strategy & Tech Innovation firms, including Chairman and CEO positions within global top 5 Insight and Innovation agencies. As an active business mentor during the past 15 years he has held several partner & board advisory positions in firms within Insights & Strategy, AI & Data, Business & Media consulting.

Timothy Johnson, MA

Director, Global CoTeaching Lab

Timothy Johnson, MA, works on the operationalization of the Convention on Biological Diversity and the Nagoya Protocol. His efforts include traceability through blockchain technology, private sector engagement in the Access on Benefit-sharing mechanism, and network-building.

Elazer R. Edelman, MD, PhD

Director, MIT Institute for Medical Engineering and Science (IMES) 

​Elazer R. Edelman, M.D., Ph.D., directs MIT’s Institute for Medical Engineering and Science (IMES) and Clinical Research Center (CRC) as well as the Harvard-MIT Biomedical Engineering Center (BMEC). He is the Edward J. Poitras Professor in Medical Engineering and Science at MIT, Professor of Medicine at Harvard Medical School, and Senior Attending Physician in the coronary care unit at the Brigham and Women’s Hospital in Boston.

Mercedes Balcells, PhD

Co-Founder and Scientific Advisor

Mercedes Balcells, PhD, is a Principal Research Scientist at the MIT Institute for Medical Engineering and Science as well as a Profesora Titular in Bioengineering at Institut Químic de Sarrià in Barcelona. Dr. Balcells founded and directs the MIT-Spain Program and she is also Program Chair of IDEA² Global. She embraces working with clinicians and industry partners to accelerate translation from bench to bedside.

Martha Gray, PhD

Martha Gray, PhD, directed for 13+ years the Harvard-MIT Division of Health Sciences and Technology (HST). She currently directs MIT linQ. She has served as an MIT faculty for nearly three decades and has held numerous leadership positions. She has a multifaceted career in which she has built programs to drive biomedical technology innovation.

Ellen Roche, PhD

Ellen Roche, PhD, is the Helmholtz Career Development Professor in the Mechanical Engineering Department and the Institute for Medical Engineering and Science. Her research incorporates engineering advances in manufacturing technologies and computational analysis in the device design process to develop novel therapeutic strategies for organ assistance and tissue repair. She has experience in both the Medtech industry and academia.

Lydia Bourouiba, PhD

Lydia Bourouiba is an Associate Professor at the Massachusetts Institute of Technology, where she directs the Fluid Dynamics of Disease Transmission Laboratory. Her research leverages advanced fluid dynamics experiments at various scales, biophysics, and applied mathematics to elucidate interfacial flow and fluid fragmentation processes driving mixing, transport, and persistence of particles and microorganisms relevant to disease transmission in human, animal, and plant populations.

Brian W. Anthony, PhD

Brian W. Anthony, PhD, is an Associate Director of MIT nano Program and Co-Director of the Medical Electronic Device Realization Center. With over 25 years experience in product realization, Dr. Anthony designs instruments and techniques to monitor and control physical systems.

Natalie Artzi, PhD

Natalie Artzi, PhD, is an Assistant Professor at Brigham and Women’s Hospital, Harvard Medical School. She is a principal Research Scientist at the MIT IMES, and is an Associate member of the Broad Institute of Harvard and MIT. Leveraging material science, chemistry, imaging and biology, Dr. Artzi’s group is dedicated to designing smart material platforms and medical devices to improve human health.

Irene Bosch, PhD

Irene Bosch, PhD, graduated from Harvard University and did Post-doctoral training at the Dana-Farber Cancer Institute, in Boston. Dr. Bosch is an expert in Dengue virus, and has traveled and collaborated extensively in the Americas to study Dengue virus biology. Dr. Bosch is CEO and founder of E25Bio.

Vipul Chitalia, MD, PhD

Vipul Chitalia, MD, PhD, is an Associate Professor in the Renal Section of Department of Medicine at Boston University and an affiliate of IMES, MIT. He is a practicing nephrologist at Boston Medical Center and a physician-scientist addressing major bottlenecks in the field of nephrology and transplantation. His NIH-funded laboratory performs translational research to improve the management of patients with kidney failure on dialysis.

Frederik Claeyssens, PhD

Frederik Claeyssens, PhD, is a Reader in Biomaterials at the Department of Materials Science and Engineering at the University of Sheffield. His research group is based in the Kroto Research Institute at the University of Sheffield. Frederik´s research expertise focuses mainly on laser processing of biomaterials, and its applications.

Àgata Gelabertó, MBA

Àgata Gelabertó, MBA, is an Expert in Business Innovation. She is an experienced businesswomen currently leading the Innovation and New Business division at Idilia Foods. She is also Vice President of AME (Spanish Society of Microtia), founder and CEO of Regenear and Regional Coordinator of Advisory Board Program at EJE&CON.

Kimberly Hamad-Schifferli, PhD

Kimberly Hamad-Schifferli, PhD, was a postdoctoral associate in the Molecular Machines at the MIT Media Lab. She joined MIT in the Department of Mechanical Engineering and the Department of Biological Engineering as a faculty member from 2002-2012. She currently leads the Nanobiointerfaces Lab in the Department of Engineering at UMass Boston.

Kumaran Kolandaivelu, MD, PhD

Kumaran Kolandaivelu, MD, PhD, is the Medical Director of the MIT/IMES Clinical Research Center, Associate Director of the Harvard Catalyst / MIT Bridge, Instructor in Medicine at Harvard Medical School and on staff in the Cardiology Division of Brigham and Women’s Hospital (BWH). His research defines local and systemic factors underlying outcome variability to cardiovascular treatments, bridging clinical association to causal mechanism.

Tami Lieberman, PhD

Tami Lieberman, PhD, is the Hermann L. F. von Helmholtz Career Development Assistant Professor in the Department of Civil and Environmental Engineering and the Institute for Medical Engineering and Science at MIT. She leads a computational and experimental research group focused on uncovering the principles governing colonization, niche range, and personalization in the human microbiome.

Jordi Martorell, PhD

Jordi Martorell, PhD, is Head of the Vascular Engineering and Applied Biomedicine Group at IQS School of Engineering (Barcelona, Spain). His research has focused on vascular biology for more than ten years at MIT and IQS.  He has collaborated with medical device companies to improve the design of coronary stents and arterial valves. He is also the CEO and Co-Founder of Aortyx.

Gemma Molins, MS

Gemma Molins, MS, graduated in Chemistry and Bioengineering from IQS School of Engineering, Spain. Her research work includes biomaterials and nanocarriers development for targeted delivery. She has also led the development of biomaterials for endovascular cardiology and neuroradiology in the medical device industry.

Camila Maciel de Oliveira, MD, PhD

Camila Maciel de Oliveira, MD, Ph.D., is an Endocrinologist, Professor of the Department of Integrative Medicine, Federal University of Paraná (Brazil) and Unipac. Ph.D. in Cardiology (Heart Institute, Brazil) and postdoc in Epidemiology and Preventive Medicine (Boston University). She was a visiting researcher at Brigham and Women´s Hospital, Harvard Medical School (2018-2020) and at Framingham Heart Study (2017-2020). Currently, she is a visiting scholar at the Global CoCreation.

Pedro Melgar-Lesmes, PhD

Pedro Melgar-Lesmes, PhD, is a Researcher at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) in Barcelona and an affiliate of IMES, MIT. He is a scientist interested in optimizing state-of-the-art technologies (nanomedicine & tissue engineering) to modulate tissue regeneration with special emphasis in hepatic regeneration. His lab performs translational research in new diagnostic and therapeutic strategies in liver diseases.

Farhad Rikhtegar Nezami, PhD

Farhad Rikhtegar Nezami, PhD, graduated in Mechanical Engineering from ETH Zurich and is currently affiliated as a postdoctoral associate and project leader in the Institute for Medical Engineering and Science at MIT. His work embraces precision medicine and personalized therapy and developing predictive/prognostic tools incorporating clinical data and machine-learning algorithms.

Javier Pedreño, MD, PhD

Javier Pedreño, MD, PhD, is CEO and Scientific Founder of Alxerion Biotech. In addition, he serves as a Profesor de Investigación in Translational Medicine at Austral University Medical School (Buenos Aires, Argentina). Dr. Pedreño brings a wealth of both academic and commercial scientific research and novel drug development experience.

Paola Divieti Pajevic, MD, PhD

Paola Divieti Pajevic, MD, PhD, is an Associate Professor of Molecular and Cell Biology at Boston University, Goldman School of Dental Medicine. She is also the Director of the Bone Cell Core, Center for Skeletal Research and a member of the Endocrine Unit at Massachusetts General Hospital in Boston.

José M. de la Torre Hernandez, MD, PhD

José M. de la Torre Hernandez, MD, PhD, is head of the interventional cardiology dpt. at Hospital Universitario Marqués de Valdecilla (Santander, Spain). Dr. de la Torre Hernandez has more than 20 year of experience as a research clinician and has recently performed a 12-month research stay at MIT IMES as a visiting scholar.

Rami Tzafriri, PhD

Rami Tzafriri, PhD, received his PhD from the Hebrew University of Jerusalem and then hen joined Professor Elazer Edelman’s laboratory at MIT as a Postdoctoral Scientist, where he developed quantitative models for growth factor biology and endovascular drug delivery. He is the Director of Research and Innovation at CBSET, a pre-clinical research organization dedicated to research and the advancement of early-stage biomedical technologies.